Global Q Fever Market Size, Status and Forecast 2021-2027

SKU ID :QYR-17783220 | Published Date: 23-Mar-2021 | No. of pages: 98
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Q Fever Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Acute Q Fever 1.2.3 Chronic Q Fever 1.3 Market by Application 1.3.1 Global Q Fever Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals & Clinics 1.3.3 Diagnostic Centers 1.3.4 Surgical Centers 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Q Fever Market Perspective (2016-2027) 2.2 Q Fever Growth Trends by Regions 2.2.1 Q Fever Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Q Fever Historic Market Share by Regions (2016-2021) 2.2.3 Q Fever Forecasted Market Size by Regions (2022-2027) 2.3 Q Fever Industry Dynamic 2.3.1 Q Fever Market Trends 2.3.2 Q Fever Market Drivers 2.3.3 Q Fever Market Challenges 2.3.4 Q Fever Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Q Fever Players by Revenue 3.1.1 Global Top Q Fever Players by Revenue (2016-2021) 3.1.2 Global Q Fever Revenue Market Share by Players (2016-2021) 3.2 Global Q Fever Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Q Fever Revenue 3.4 Global Q Fever Market Concentration Ratio 3.4.1 Global Q Fever Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Q Fever Revenue in 2020 3.5 Q Fever Key Players Head office and Area Served 3.6 Key Players Q Fever Product Solution and Service 3.7 Date of Enter into Q Fever Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Q Fever Breakdown Data by Type 4.1 Global Q Fever Historic Market Size by Type (2016-2021) 4.2 Global Q Fever Forecasted Market Size by Type (2022-2027) 5 Q Fever Breakdown Data by Application 5.1 Global Q Fever Historic Market Size by Application (2016-2021) 5.2 Global Q Fever Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Q Fever Market Size (2016-2027) 6.2 North America Q Fever Market Size by Type 6.2.1 North America Q Fever Market Size by Type (2016-2021) 6.2.2 North America Q Fever Market Size by Type (2022-2027) 6.2.3 North America Q Fever Market Size by Type (2016-2027) 6.3 North America Q Fever Market Size by Application 6.3.1 North America Q Fever Market Size by Application (2016-2021) 6.3.2 North America Q Fever Market Size by Application (2022-2027) 6.3.3 North America Q Fever Market Size by Application (2016-2027) 6.4 North America Q Fever Market Size by Country 6.4.1 North America Q Fever Market Size by Country (2016-2021) 6.4.2 North America Q Fever Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Q Fever Market Size (2016-2027) 7.2 Europe Q Fever Market Size by Type 7.2.1 Europe Q Fever Market Size by Type (2016-2021) 7.2.2 Europe Q Fever Market Size by Type (2022-2027) 7.2.3 Europe Q Fever Market Size by Type (2016-2027) 7.3 Europe Q Fever Market Size by Application 7.3.1 Europe Q Fever Market Size by Application (2016-2021) 7.3.2 Europe Q Fever Market Size by Application (2022-2027) 7.3.3 Europe Q Fever Market Size by Application (2016-2027) 7.4 Europe Q Fever Market Size by Country 7.4.1 Europe Q Fever Market Size by Country (2016-2021) 7.4.2 Europe Q Fever Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Q Fever Market Size (2016-2027) 8.2 Asia-Pacific Q Fever Market Size by Type 8.2.1 Asia-Pacific Q Fever Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Q Fever Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Q Fever Market Size by Type (2016-2027) 8.3 Asia-Pacific Q Fever Market Size by Application 8.3.1 Asia-Pacific Q Fever Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Q Fever Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Q Fever Market Size by Application (2016-2027) 8.4 Asia-Pacific Q Fever Market Size by Region 8.4.1 Asia-Pacific Q Fever Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Q Fever Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Q Fever Market Size (2016-2027) 9.2 Latin America Q Fever Market Size by Type 9.2.1 Latin America Q Fever Market Size by Type (2016-2021) 9.2.2 Latin America Q Fever Market Size by Type (2022-2027) 9.2.3 Latin America Q Fever Market Size by Type (2016-2027) 9.3 Latin America Q Fever Market Size by Application 9.3.1 Latin America Q Fever Market Size by Application (2016-2021) 9.3.2 Latin America Q Fever Market Size by Application (2022-2027) 9.3.3 Latin America Q Fever Market Size by Application (2016-2027) 9.4 Latin America Q Fever Market Size by Country 9.4.1 Latin America Q Fever Market Size by Country (2016-2021) 9.4.2 Latin America Q Fever Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Q Fever Market Size (2016-2027) 10.2 Middle East & Africa Q Fever Market Size by Type 10.2.1 Middle East & Africa Q Fever Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Q Fever Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Q Fever Market Size by Type (2016-2027) 10.3 Middle East & Africa Q Fever Market Size by Application 10.3.1 Middle East & Africa Q Fever Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Q Fever Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Q Fever Market Size by Application (2016-2027) 10.4 Middle East & Africa Q Fever Market Size by Country 10.4.1 Middle East & Africa Q Fever Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Q Fever Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Yashica Pharmaceuticals Private Limited (India) 11.1.1 Yashica Pharmaceuticals Private Limited (India) Company Details 11.1.2 Yashica Pharmaceuticals Private Limited (India) Business Overview 11.1.3 Yashica Pharmaceuticals Private Limited (India) Q Fever Introduction 11.1.4 Yashica Pharmaceuticals Private Limited (India) Revenue in Q Fever Business (2016-2021) 11.1.5 Yashica Pharmaceuticals Private Limited (India) Recent Development 11.2 Merck & Co. (US) 11.2.1 Merck & Co. (US) Company Details 11.2.2 Merck & Co. (US) Business Overview 11.2.3 Merck & Co. (US) Q Fever Introduction 11.2.4 Merck & Co. (US) Revenue in Q Fever Business (2016-2021) 11.2.5 Merck & Co. (US) Recent Development 11.3 Atox Bio (Israel) 11.3.1 Atox Bio (Israel) Company Details 11.3.2 Atox Bio (Israel) Business Overview 11.3.3 Atox Bio (Israel) Q Fever Introduction 11.3.4 Atox Bio (Israel) Revenue in Q Fever Business (2016-2021) 11.3.5 Atox Bio (Israel) Recent Development 11.4 Teva Pharmaceutical Industries (Israel) 11.4.1 Teva Pharmaceutical Industries (Israel) Company Details 11.4.2 Teva Pharmaceutical Industries (Israel) Business Overview 11.4.3 Teva Pharmaceutical Industries (Israel) Q Fever Introduction 11.4.4 Teva Pharmaceutical Industries (Israel) Revenue in Q Fever Business (2016-2021) 11.4.5 Teva Pharmaceutical Industries (Israel) Recent Development 11.5 Basilea Pharmaceutica Ltd. (Switzerland) 11.5.1 Basilea Pharmaceutica Ltd. (Switzerland) Company Details 11.5.2 Basilea Pharmaceutica Ltd. (Switzerland) Business Overview 11.5.3 Basilea Pharmaceutica Ltd. (Switzerland) Q Fever Introduction 11.5.4 Basilea Pharmaceutica Ltd. (Switzerland) Revenue in Q Fever Business (2016-2021) 11.5.5 Basilea Pharmaceutica Ltd. (Switzerland) Recent Development 11.6 MELINTA THERAPEUTICS(US) 11.6.1 MELINTA THERAPEUTICS(US) Company Details 11.6.2 MELINTA THERAPEUTICS(US) Business Overview 11.6.3 MELINTA THERAPEUTICS(US) Q Fever Introduction 11.6.4 MELINTA THERAPEUTICS(US) Revenue in Q Fever Business (2016-2021) 11.6.5 MELINTA THERAPEUTICS(US) Recent Development 11.7 Pfizer (US) 11.7.1 Pfizer (US) Company Details 11.7.2 Pfizer (US) Business Overview 11.7.3 Pfizer (US) Q Fever Introduction 11.7.4 Pfizer (US) Revenue in Q Fever Business (2016-2021) 11.7.5 Pfizer (US) Recent Development 11.8 Cipla Inc. (India) 11.8.1 Cipla Inc. (India) Company Details 11.8.2 Cipla Inc. (India) Business Overview 11.8.3 Cipla Inc. (India) Q Fever Introduction 11.8.4 Cipla Inc. (India) Revenue in Q Fever Business (2016-2021) 11.8.5 Cipla Inc. (India) Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
List of Tables Table 1. Global Q Fever Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Acute Q Fever Table 3. Key Players of Chronic Q Fever Table 4. Global Q Fever Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Q Fever Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Q Fever Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Q Fever Market Share by Regions (2016-2021) Table 8. Global Q Fever Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Q Fever Market Share by Regions (2022-2027) Table 10. Q Fever Market Trends Table 11. Q Fever Market Drivers Table 12. Q Fever Market Challenges Table 13. Q Fever Market Restraints Table 14. Global Q Fever Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Q Fever Market Share by Players (2016-2021) Table 16. Global Top Q Fever Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Q Fever as of 2020) Table 17. Ranking of Global Top Q Fever Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Q Fever Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Q Fever Product Solution and Service Table 21. Date of Enter into Q Fever Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Q Fever Market Size by Type (2016-2021) (US$ Million) Table 24. Global Q Fever Revenue Market Share by Type (2016-2021) Table 25. Global Q Fever Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Q Fever Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Q Fever Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Q Fever Revenue Market Share by Application (2016-2021) Table 29. Global Q Fever Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Q Fever Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Q Fever Market Size by Type (2016-2021) (US$ Million) Table 32. North America Q Fever Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Q Fever Market Size by Application (2016-2021) (US$ Million) Table 34. North America Q Fever Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Q Fever Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Q Fever Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Q Fever Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Q Fever Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Q Fever Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Q Fever Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Q Fever Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Q Fever Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Q Fever Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Q Fever Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Q Fever Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Q Fever Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Q Fever Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Q Fever Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Q Fever Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Q Fever Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Q Fever Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Q Fever Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Q Fever Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Q Fever Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Q Fever Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Q Fever Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Q Fever Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Q Fever Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Q Fever Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Q Fever Market Size by Country (2022-2027) & (US$ Million) Table 61. Yashica Pharmaceuticals Private Limited (India) Company Details Table 62. Yashica Pharmaceuticals Private Limited (India) Business Overview Table 63. Yashica Pharmaceuticals Private Limited (India) Q Fever Product Table 64. Yashica Pharmaceuticals Private Limited (India) Revenue in Q Fever Business (2016-2021) & (US$ Million) Table 65. Yashica Pharmaceuticals Private Limited (India) Recent Development Table 66. Merck & Co. (US) Company Details Table 67. Merck & Co. (US) Business Overview Table 68. Merck & Co. (US) Q Fever Product Table 69. Merck & Co. (US) Revenue in Q Fever Business (2016-2021) & (US$ Million) Table 70. Merck & Co. (US) Recent Development Table 71. Atox Bio (Israel) Company Details Table 72. Atox Bio (Israel) Business Overview Table 73. Atox Bio (Israel) Q Fever Product Table 74. Atox Bio (Israel) Revenue in Q Fever Business (2016-2021) & (US$ Million) Table 75. Atox Bio (Israel) Recent Development Table 76. Teva Pharmaceutical Industries (Israel) Company Details Table 77. Teva Pharmaceutical Industries (Israel) Business Overview Table 78. Teva Pharmaceutical Industries (Israel) Q Fever Product Table 79. Teva Pharmaceutical Industries (Israel) Revenue in Q Fever Business (2016-2021) & (US$ Million) Table 80. Teva Pharmaceutical Industries (Israel) Recent Development Table 81. Basilea Pharmaceutica Ltd. (Switzerland) Company Details Table 82. Basilea Pharmaceutica Ltd. (Switzerland) Business Overview Table 83. Basilea Pharmaceutica Ltd. (Switzerland) Q Fever Product Table 84. Basilea Pharmaceutica Ltd. (Switzerland) Revenue in Q Fever Business (2016-2021) & (US$ Million) Table 85. Basilea Pharmaceutica Ltd. (Switzerland) Recent Development Table 86. MELINTA THERAPEUTICS(US) Company Details Table 87. MELINTA THERAPEUTICS(US) Business Overview Table 88. MELINTA THERAPEUTICS(US) Q Fever Product Table 89. MELINTA THERAPEUTICS(US) Revenue in Q Fever Business (2016-2021) & (US$ Million) Table 90. MELINTA THERAPEUTICS(US) Recent Development Table 91. Pfizer (US) Company Details Table 92. Pfizer (US) Business Overview Table 93. Pfizer (US) Q Fever Product Table 94. Pfizer (US) Revenue in Q Fever Business (2016-2021) & (US$ Million) Table 95. Pfizer (US) Recent Development Table 96. Cipla Inc. (India) Company Details Table 97. Cipla Inc. (India) Business Overview Table 98. Cipla Inc. (India) Revenue in Q Fever Business (2016-2021) & (US$ Million) Table 99. Cipla Inc. (India) Recent Development Table 100. Research Programs/Design for This Report Table 101. Key Data Information from Secondary Sources Table 102. Key Data Information from Primary Sources List of Figures Figure 1. Global Q Fever Market Share by Type: 2020 VS 2027 Figure 2. Acute Q Fever Features Figure 3. Chronic Q Fever Features Figure 4. Global Q Fever Market Share by Application: 2020 VS 2027 Figure 5. Hospitals & Clinics Case Studies Figure 6. Diagnostic Centers Case Studies Figure 7. Surgical Centers Case Studies Figure 8. Q Fever Report Years Considered Figure 9. Global Q Fever Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Q Fever Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Q Fever Market Share by Regions: 2020 VS 2027 Figure 12. Global Q Fever Market Share by Regions (2022-2027) Figure 13. Global Q Fever Market Share by Players in 2020 Figure 14. Global Top Q Fever Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Q Fever as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Q Fever Revenue in 2020 Figure 16. Global Q Fever Revenue Market Share by Type (2016-2021) Figure 17. Global Q Fever Revenue Market Share by Type (2022-2027) Figure 18. North America Q Fever Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Q Fever Market Share by Type (2016-2027) Figure 20. North America Q Fever Market Share by Application (2016-2027) Figure 21. North America Q Fever Market Share by Country (2016-2027) Figure 22. United States Q Fever Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Q Fever Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Q Fever Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Q Fever Market Share by Type (2016-2027) Figure 26. Europe Q Fever Market Share by Application (2016-2027) Figure 27. Europe Q Fever Market Share by Country (2016-2027) Figure 28. Germany Q Fever Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Q Fever Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Q Fever Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Q Fever Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Q Fever Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Q Fever Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Q Fever Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Q Fever Market Share by Type (2016-2027) Figure 36. Asia-Pacific Q Fever Market Share by Application (2016-2027) Figure 37. Asia-Pacific Q Fever Market Share by Region (2016-2027) Figure 38. China Q Fever Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Q Fever Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Q Fever Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Q Fever Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Q Fever Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Q Fever Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Q Fever Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Q Fever Market Share by Type (2016-2027) Figure 46. Latin America Q Fever Market Share by Application (2016-2027) Figure 47. Latin America Q Fever Market Share by Country (2016-2027) Figure 48. Mexico Q Fever Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Q Fever Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Q Fever Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Q Fever Market Share by Type (2016-2027) Figure 52. Middle East & Africa Q Fever Market Share by Application (2016-2027) Figure 53. Middle East & Africa Q Fever Market Share by Country (2016-2027) Figure 54. Turkey Q Fever Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Q Fever Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Q Fever Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Yashica Pharmaceuticals Private Limited (India) Revenue Growth Rate in Q Fever Business (2016-2021) Figure 58. Merck & Co. (US) Revenue Growth Rate in Q Fever Business (2016-2021) Figure 59. Atox Bio (Israel) Revenue Growth Rate in Q Fever Business (2016-2021) Figure 60. Teva Pharmaceutical Industries (Israel) Revenue Growth Rate in Q Fever Business (2016-2021) Figure 61. Basilea Pharmaceutica Ltd. (Switzerland) Revenue Growth Rate in Q Fever Business (2016-2021) Figure 62. MELINTA THERAPEUTICS(US) Revenue Growth Rate in Q Fever Business (2016-2021) Figure 63. Pfizer (US) Revenue Growth Rate in Q Fever Business (2016-2021) Figure 64. Cipla Inc. (India) Revenue Growth Rate in Q Fever Business (2016-2021) Figure 65. Bottom-up and Top-down Approaches for This Report Figure 66. Data Triangulation Figure 67. Key Executives Interviewed
Yashica Pharmaceuticals Private Limited (India) Merck & Co. (US) Atox Bio (Israel) Teva Pharmaceutical Industries (Israel) Basilea Pharmaceutica Ltd. (Switzerland) MELINTA THERAPEUTICS(US) Pfizer (US) Cipla Inc. (India)
  • PRICE
  • $3900
    $7800
    $5850
    Buy Now

Our Clients